Decolonizing the Pandemic Treaty Through Vaccine Equity
Putting vaccine equity at the center of a pandemic treaty will already be a huge step towards global health’s decolonization.

Putting vaccine equity at the center of a pandemic treaty will already be a huge step towards global health’s decolonization.
The pandemic has laid bare the lack of regulation for the sharing of intellectual property needed for an effective and equitable response.
An ongoing patent battle over omega-3 fatty acids may have broad implications for the marketing of generic drugs.
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of June 2021.
Going forward, practical solutions should focus on scaling up manufacturing and supply, and improving access and affordability.
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of May 2021.
An explanation of the WTO waiver of COVID-19 intellectual property, what the U.S. declaration of support means, and likely effects of the waiver.
Patients may face increased out-of-pocket drug costs as a result of a rule finalized by the Centers for Medicare & Medicaid Services in July 2020.
Three developments may have effects on the use of patents to fend off competition for therapeutic monoclonal antibodies.